DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·07/23/2025 12:08:15
Listen to the news

Gainers

  • Abivax (NASDAQ:ABVX) shares rose 468.8% to $56.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $634.7 million.
  • Clearside Biomedical (NASDAQ:CLSD) shares increased by 68.32% to $0.59. The company's market cap stands at $27.3 million.
  • Anebulo Pharmaceuticals (NASDAQ:ANEB) stock rose 63.93% to $3.0. The company's market cap stands at $75.1 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 47.36% to $0.03. The market value of their outstanding shares is at $7.7 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock rose 31.13% to $12.38. The market value of their outstanding shares is at $7.8 million.
  • Polyrizon (NASDAQ:PLRZ) stock increased by 24.13% to $1.8. The market value of their outstanding shares is at $7.7 million.

Losers

  • Imunon (NASDAQ:IMNN) stock fell 10.8% to $0.56 during Wednesday's pre-market session. The company's market cap stands at $10.9 million.
  • MEI Pharma (NASDAQ:MEIP) shares fell 10.35% to $6.15. The market value of their outstanding shares is at $45.7 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock decreased by 9.1% to $2.0. The market value of their outstanding shares is at $5.2 million.
  • Telix Pharmaceuticals (NASDAQ:TLX) shares decreased by 8.05% to $14.97. The market value of their outstanding shares is at $5.4 billion.
  • SeaStar Medical Holding (NASDAQ:ICU) shares fell 6.56% to $0.72. The market value of their outstanding shares is at $16.9 million.
  • SAB Biotherapeutics (NASDAQ:SABS) shares fell 6.52% to $2.44. The company's market cap stands at $24.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.